How Long Can You Use Wegovy for Weight Loss?

NICE recommends a maximum of two years on Wegovy for NHS patients within specialist weight management services — private use follows the licensed SmPC, which carries no fixed duration ceiling.
Stopping Wegovy typically leads to gradual weight regain; clinical trial data show most of the lost weight returns within a year of discontinuation without continued lifestyle support.
A prescriber reviews your progress before every repeat, if you have not lost at least 5% of your starting weight after six months at the maintenance dose, continuing is reconsidered.
Long-term use requires ongoing clinical oversight, not a one-off assessment; safety monitoring, dose suitability and comorbidities are re-evaluated at each review.

Most people can use Wegovy for weight loss for as long as it continues to work and remains clinically appropriate — which for many adults means ongoing treatment rather than a fixed stop date. NICE guidance for NHS use sets a maximum of two years for semaglutide within specialist services, but private prescribing follows the licensed SmPC, which does not impose a hard time limit. These are prescription-only medicines; a prescriber decides how long treatment is right for you, based on your progress, your health, and any side effects along the way.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The real picture on Wegovy duration: what the guidance says and what happens when you stop

You've reached your target weight, so what now?

Picture this: six or eight months in, your clothes fit differently, your GP has noticed, and you're wondering whether you still need the pen waiting in the fridge door each week. It's one of the most common questions our prescribers hear. The honest answer is that Wegovy works by actively suppressing appetite through the GLP-1 pathway, and when you stop, that pharmacological effect stops too.

Clinical evidence bears this out clearly. In the STEP 1 extension study, participants who discontinued semaglutide 2.4mg regained most of the weight they had lost within 12 months, even when they continued with lifestyle changes. Weight regain was gradual rather than sudden, but the trajectory was consistent. This does not mean treatment must last forever; it means the decision to stop deserves the same clinical thought as the decision to start.

Questions about how long you can realistically stay on Wegovy depend on your health picture as a whole, not on any fixed calendar. A prescriber weighs up ongoing benefit against any side effects, your weight trajectory, and whether your original weight-related conditions have improved.

What the NICE guidance actually says about duration

For NHS patients, NICE's technology appraisal TA875 is specific: semaglutide (Wegovy) should be used for a maximum of two years, and only within a specialist weight management service offering multidisciplinary support. That two-year cap applies to the NHS route. The guidance also states that if a patient has not achieved at least 5% weight loss after six months at the maintenance dose, continuing is not recommended.

Private prescribing operates under the medicine's licensed SmPC, which does not set a hard two-year ceiling. That makes the prescriber's ongoing clinical judgment the governing factor rather than a fixed end date. In practice, this means how long you take Wegovy is a moving clinical conversation, not a number written in stone at the start.

The 5% threshold matters in both settings. It is a practical checkpoint: if the medicine is not producing meaningful weight loss after six months at the highest dose you tolerate, a prescriber will discuss whether continuing makes sense. This is standard clinical care, not a failure, some people respond better to a different treatment or a different approach.

Dose titration affects the timeline too

One thing that catches people out is how the titration schedule stretches the early months. Wegovy starts at 0.25mg weekly, stepping up through 0.5mg, 1.0mg, 1.7mg and finally 2.4mg, with roughly four weeks at each level. That's nearly five months before you reach the maintenance dose at which the STEP 1 trial showed around 15% average weight reduction over 68 weeks. The six-month checkpoint for the 5% rule is counted from the maintenance dose, not from day one.

For those using the newer 7.2mg dose (approved by the MHRA in January 2026, with a dedicated single-dose pen approved in April 2026), the titration path is longer still. The MHRA's approval of the 7.2mg pen confirmed that 0.25mg remains the starting dose and that the maximum dose is reached through the same stepwise schedule. Understanding this timeline helps set realistic expectations for how long Wegovy takes to show meaningful results.

If you are wondering whether the longer duration available through ongoing semaglutide treatment is right for you, that conversation belongs with a prescriber reviewing your full history. Cost is a real consideration for longer treatment; you can explore how Wegovy fits into the range of available options before committing to a consultation.

Planning for treatment and what comes after

Longer-term use is not a failure of willpower or a sign that the medicine hasn't worked. Obesity is a chronic condition with a biological basis, and many clinical guidelines now treat it accordingly. The question is not whether you should need the medicine indefinitely, but whether continuing it is medically appropriate and practically sustainable for you.

That sustainability question includes cost, which is worth factoring in from the start. A transparent single price covering consultation, prescription, and free next-working-day delivery matters more over a longer treatment period than it does for a single month. Wegovy pricing and what's included is worth reviewing alongside the clinical picture.

When you're ready to talk through how long treatment might make sense for your situation, a prescriber at our pharmacy will review your consultation the same working day. There are no subscriptions and no auto-renewals; every repeat is a fresh clinical review. Speak to our prescribers through our free consultation page to start that conversation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions